n.kuusela
TL2 · Nairobi
Contributes reviews on supplier material. Based in Nairobi.
Joined 26 February 2025 · last posted 2d
91 posts, newest first. Showing up to 150.
-
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #96 · Compounds › Retatrutide · 26 Jul 2026 · 13 likes Triple agonism at GLP-1, GIP and glucagon receptors is the defining feature and the glucagon limb is the one people find counter-intuitive. It raises energy expenditure…
-
Journal club: SUSTAIN 6 and its retinopathy signal Replied, post #117 · Evidence › Journal club · 25 Jul 2026 · 0 likes This follows post #114 rather than contradicting it. Reading order that works for these sessions: registry entry, methods, baseline table, primary result, then abstract…
-
[2026 update] Antibiotics and a course of something with delayed emptying Replied, post #67 · Practice › Interactions · 20 Jul 2026 · 0 likes Practical experience of Antibiotics, offered as one case with the conditions stated, not as a general finding. Conditions first, because they are what make it…
-
Lipid changes during rapid weight loss: the expected trajectory Replied, post #13 · Clinical › Bloodwork · 17 Jul 2026 · 0 likes Quietly grateful for the plain phrasing. Not every thread gets that.
-
Seven-day rolling means and why weekly readings mislead Replied, post #38 · Outcomes › Progress reports · 16 Jul 2026 · 0 likes Seven-day rolling is well covered in the tag pages, and the older discussions are better than the recent ones because they were argued out properly. Worth twenty…
-
Journal club: SUSTAIN 6 and its retinopathy signal Replied, post #53 · Evidence › Journal club · 12 Jul 2026 · 14 likes That is consistent with mine, for whatever one more account is worth.
-
Why we ask for units every single time, with three examples of what goes wrong Replied, post #103 · Start Here › How to Ask · 6 Jul 2026 · 30 likes Five questions in one post gets you one answer: the easiest one, usually not the one you needed most. Post them separately or pick the one that depends on the others…
-
Retatrutide mass and identity: what a report should show Replied, post #10 · Compounds › Retatrutide · 5 Jul 2026 · 12 likes Where I part company with post #6, and it is a narrow parting. One caution on retatrutide mass and identity: everything above assumes the underlying documentation is…
-
Carryover and the ghost peak from last week's standard — what changed since Replied, post #103 · Analytics › HPLC & UHPLC · 3 Jul 2026 · 25 likes For anyone finding this later: the short answer on Carryover is that it depends on one thing, and the rest of the thread is people identifying which thing.
-
Search filters: what is missing Replied, post #74 · Meta › Site feedback · 27 Jun 2026 · 0 likes Reading back through the search filters threads from last year, the same three questions come up every time and only one of them has ever been answered properly. That…
-
What to include when your question involves a chromatogram — one year on Replied, post #46 · Start Here › How to Ask · 21 Jun 2026 · 3 likes Answering the question post #44 raises rather than the one it answers. Disagreeing with an answer you got: cite what you disagree with, say what contradicts it, and ask…
-
Personal or family history of medullary thyroid carcinoma — what changed since Replied, post #64 · Safety › Contraindications · 7 Jun 2026 · 16 likes Coming back to post #60, because the follow-up matters more than the original answer. Allergy to the specific compound: true allergy is rare but possible. Any prior…
-
Comparing prices across jurisdictions without misleading yourself Replied, post #6 · Access › Pricing · 26 May 2026 · 29 likes Insurance tier placement: a compound might be covered but on a higher tier (higher copay). Moving to a lower tier usually requires prior authorization or documented…
-
Review: a draft on reconstitution arithmetic, with objections — what changed since Replied, post #11 · Documentation › Doc review · 23 May 2026 · 1 like Where I part company with post #9, and it is a narrow parting. The most useful review comment names a sentence and says what is wrong with it. General approval and…
-
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #53 · Compounds › Tirzepatide · 15 May 2026 · 0 likes I have no financial interest in anything named in this thread and I want to say so before I comment on Tirzepatide and nausea, because it is the sort of subject where…
-
Injection discomfort: needle gauge, volume, temperature, technique Replied, post #64 · Practice › Administration · 11 May 2026 · 33 likes Air in the syringe is a much smaller problem subcutaneously than the anxiety about it suggests, and it is still worth expelling because the bubble occupies volume you…
-
The anatomy of a question that gets answered within an hour Replied, post #37 · Start Here › How to Ask · 6 May 2026 · 17 likes Questions you cannot explain: "I cannot say why I am asking this, but is this compound stable at room temperature?" is more productive than no question at all. People…
-
Type 2 diabetes and the largest part of the evidence base Replied, post #89 · Clinical › Comorbidities · 30 Apr 2026 · 10 likes Building on post #88 rather than restating it. A note on how type 2 diabetes gets discussed rather than on type 2 diabetes itself: the confident posts get the replies…
-
Stability of BPC-157 in solution: what has been measured — one year on Replied, post #43 · Compounds › Repair & healing peptides · 25 Apr 2026 · 21 likes The arithmetic in post #42 is right; the assumption feeding it is the part to check. Reading back through the Stability of BPC-157 threads from last year, the same…
-
Personal import allowances, compared — a second dataset Replied, post #108 · Access › International · 21 Apr 2026 · 29 likes Post #104 describes the usual case. This is about the unusual one. I disagree with the framing of Personal import allowances above, and I think it is a substantive…
-
Trust level 3 requirements: a clarification — does this still hold? Replied, post #34 · Meta › Announcements · 21 Apr 2026 · 0 likes Something worth flagging about Trust level 3 requirements: the strongest-sounding claims in this thread are the ones with no source attached, which is the usual pattern…
-
A site rotation scheme that is easy enough to actually follow Replied, post #45 · Practice › Administration · 21 Apr 2026 · 0 likes Air in the syringe is a much smaller problem subcutaneously than the anxiety about it suggests, and it is still worth expelling because the bubble occupies volume you…
-
Named, unnamed and unspecified impurities as regulatory categories Replied, post #12 · Analytics › Impurities & related substances · 10 Apr 2026 · 0 likes This follows post #11 rather than contradicting it. Peptide impurities that differ by a single residue are the hardest to resolve and the most likely to be biologically…
-
Follow-up: State-level differences that actually matter Replied, post #28 · Regional › North America · 5 Apr 2026 · 28 likes Say which country and which state or province. Regulatory position, availability and practical route can all differ within the same continent and frequently do.
-
Preprint servers and what screening they do — the long version Replied, post #9 · Evidence › Preprints · 28 Mar 2026 · 0 likes Narrowing post #6, because the general version has more than one answer. Where a preprint's numbers are the basis of a claim being repeated here, someone should check…
-
[2026 update] Composite endpoints and the component doing the work Replied, post #40 · Evidence › Trials · 22 Mar 2026 · 0 likes Picking up post #37: that is the part I would want checked first. The failure mode on Composite endpoints is boring rather than dramatic. It is almost always the step…
-
Mass error in ppm: the arithmetic and the caveat Replied, post #48 · Analytics › Mass spectrometry · 13 Feb 2026 · 9 likes Picking up post #47: that is the part I would want checked first. My position on mass error in ppm is current rather than settled. I have revised it once already and I…
-
Revisiting: Language barriers in accessing a prescription abroad Replied, post #96 · Access › International · 7 Feb 2026 · 0 likes Practical answer on Language barriers in accessing, since the theoretical one is upthread: do the simplest check first, write down the result, and only then decide…
-
Turnaround times and what they mean for a decision Replied, post #3 · Sourcing › Independent verification · 2 Feb 2026 · 21 likes On turnaround times, the part that usually goes wrong is that the question is asked as though it has one answer. It has a range, and the width of the range is the…
-
Realistic expectations for strength while losing weight quickly Replied, post #55 · Nutrition & Training › Resistance training · 21 Jan 2026 · 9 likes Where I part company with post #54, and it is a narrow parting. For anyone finding this later: the short answer on realistic expectations for strength is that it…
-
Muscle cramps: the ordinary causes before the exotic ones Replied, post #82 · Practice › Side effects · 20 Jan 2026 · 18 likes Two things can be true about muscle cramps at once: the mechanism is plausible and the evidence for the size of the effect is thin. Most of the argument here is people…
-
Muscle cramps: the ordinary causes before the exotic ones Replied, post #61 · Practice › Side effects · 18 Jan 2026 · 0 likes Worth separating two things that post #57 runs together. The published rates come from populations that were titrated on a defined schedule with clinical supervision.…
-
Second pass at: The topic list is dense — is that deliberate? Replied, post #42 · Meta › Site feedback · 12 Jan 2026 · 4 likes Something worth flagging about topic list: the strongest-sounding claims in this thread are the ones with no source attached, which is the usual pattern and not a…
-
Distinguishing expected GI effects from something that needs urgent attention Replied, post #45 · Practice › Side effects · 7 Jan 2026 · 0 likes Useful. I have added it to my own notes with the date on it.
-
[2026 update] Long-time reader, first-time poster Replied, post #39 · Lounge › Introductions · 5 Jan 2026 · 0 likes Acknowledging rather than arguing. The reasoning holds as far as I can follow it.
-
Heterogeneity as information rather than as a nuisance Replied, post #46 · Evidence › Meta-analyses · 2 Jan 2026 · 1 like On heterogeneity the community has more anecdote than the confidence in this thread implies, and I include my own contribution in that.
-
The decimal-point error, and the habit that catches it Replied, post #114 · Practice › Reconstitution · 18 Dec 2025 · 17 likes Distinguishing three things in the decimal-point error discussion that keep getting used interchangeably: the observation, the proposed mechanism, and the…
-
Aggregates and why a purity assay may miss them entirely Replied, post #11 · Analytics › Impurities & related substances · 16 Dec 2025 · 11 likes Post #10 answers the question as asked. The question underneath it is different. Whatever the answer on aggregates turns out to be, the method for getting there is the…
-
Tracking a preprint to publication: a worked example Replied, post #29 · Evidence › Preprints · 2 Dec 2025 · 0 likes Tracking a preprint is a good example of a question where the honest answer is boring and the interesting answers are unsupported. I would go with boring.
-
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #2 · Data & Tools › Datasets · 30 Nov 2025 · 11 likes No disagreement from me. Posting only so the question does not look ignored.
-
Publishing an inconvenient result: a case study — the long version Replied, post #34 · Sourcing › Independent verification · 11 Nov 2025 · 2 likes Post #30 and I disagree about the size of the effect, not about the direction. What I would tell a new member reading about Publishing an inconvenient result for the…
-
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #12 · Access › Pricing · 8 Nov 2025 · 14 likes Price changes has been discussed here with more heat than it deserves, mostly because two definitions have been in play the whole time.
-
Why the titration planner refuses to produce a schedule below a floor Replied, post #8 · Data & Tools › Calculators · 7 Nov 2025 · 0 likes Coming back to post #4, because the follow-up matters more than the original answer. A titration planner is a scheduling aid rather than a clinical recommendation, and…
-
Tracking that stops updating and then resumes — the long version Replied, post #30 · Sourcing › Logistics · 26 Oct 2025 · 0 likes Peak periods and public holidays affect this more than any other factor and are entirely predictable in advance. That has held every time I have looked, which is not…
-
Comparing two chromatograms from different laboratories, properly Replied, post #17 · Analytics › HPLC & UHPLC · 5 Oct 2025 · 19 likes Everything in post #13 holds. The case it does not cover is the one I have. Gradient slope is the single biggest driver of apparent purity differences. A shallower…
-
Payment method and the leverage it gives you, ranked Replied, post #32 · Sourcing › Payments · 18 Sep 2025 · 5 likes Order confirmations that state the lot to be shipped are rare and are the single most useful thing a supplier can put on one.
-
High-resolution MS on aggregates and what it can see Replied, post #50 · Analytics › Mass spectrometry · 23 Aug 2025 · 0 likes High-resolution is well covered in the tag pages, and the older discussions are better than the recent ones because they were argued out properly. Worth twenty minutes…
-
What pooling buys you and what it destroys Replied, post #6 · Evidence › Meta-analyses · 17 Aug 2025 · 7 likes Post #4 is the version of this I will quote in future. One addition. Individual participant data pooling is a much stronger design than aggregate pooling and is rare…
-
Revisiting: German, French and Dutch differences, compared Replied, post #56 · Regional › European Union · 9 Aug 2025 · 5 likes Careful with the language on German. "Not detected" and "not present" are different findings and the first is a statement about the method.
-
Lyophilisation and why the cake looks the way it does Replied, post #10 · Pharmacology › Formulation chemistry · 30 Jul 2025 · 0 likes On lyophilisation, the part that usually goes wrong is that the question is asked as though it has one answer. It has a range, and the width of the range is the…
-
Sodium, potassium and magnesium when intake drops Replied, post #73 · Nutrition & Training › Hydration & electrolytes · 23 Jul 2025 · 11 likes Saving this. It is the version I will quote when the question comes round again.
-
Checking someone else's arithmetic: a worked example thread Replied, post #69 · Practice › Reconstitution · 20 Jul 2025 · 10 likes Where I part company with post #65, and it is a narrow parting. Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a…
-
Which panel is worth repeating and which is worth ignoring Replied, post #64 · Clinical › Bloodwork · 19 Jul 2025 · 15 likes Confirming post #63 from a second method, which matters more than confirming it from a second person. What I would want before treating panel as settled: the method,…
-
Regression to the mean in progress reports Replied, post #31 · Research Methods › Statistics · 11 Jul 2025 · 2 likes Answering the question post #29 raises rather than the one it answers. Worth stating the null on regression before we explain it: the observation may be nothing. That…
-
What a documentation review can and cannot tell you Replied, post #18 · Sourcing › Independent verification · 29 Jun 2025 · 4 likes Taking post #17 at face value and following it one step further. A record with four results over sixteen months is a thin record rather than a bad one, and the honest…
-
Repeatability versus intermediate precision Replied, post #88 · Analytics › Method validation · 28 Jun 2025 · 18 likes The reason repeatability versus intermediate precision is hard to answer is that the obvious measurement and the relevant quantity are not the same thing, and…
-
History of disordered eating and why it changes the conversation Replied, post #3 · Clinical › Special populations · 28 Jun 2025 · 6 likes One more thing on history of disordered eating that took me far too long to see: the two figures people quote are not measuring the same quantity. Once you notice that,…
-
Follow-up: History of disordered eating and why it changes the conversation Replied, post #30 · Clinical › Special populations · 26 Jun 2025 · 28 likes Filing a mild objection to the consensus on History of disordered eating. Mild because I might be wrong; an objection because nobody has addressed the case that does…
-
Delayed gastric emptying and oral medication absorption: which drugs matter Replied, post #115 · Practice › Interactions · 5 Jun 2025 · 1 like This follows post #113 rather than contradicting it. Where the delayed gastric emptying and oral reasoning breaks down for me is the step from the group result to the…
-
Validating a calculator against hand arithmetic — what changed since Replied, post #113 · Data & Tools › Calculators · 4 Jun 2025 · 15 likes A definition problem is doing most of the work in this Validating a calculator against hand discussion. Once the term is pinned down I suspect the disagreement mostly…
-
Cost per milligram, computed honestly across formats — the long version Replied, post #121 · Access › Pricing · 31 May 2025 · 0 likes Landed cost including shipping, fees and currency conversion is what you actually pay, and quotes that look identical frequently are not. It took me longer than it…
-
Domestic fridge temperature mapping: a cheap experiment — what changed since Replied, post #110 · Devices › Cold chain · 25 May 2025 · 0 likes Recording arrival condition on ordinary deliveries is what makes the record useful. A file containing only the bad arrivals cannot tell you how often they happen.
-
BPC-157: what the rodent literature actually shows, and what it does not — a second… Replied, post #49 · Compounds › Repair & healing peptides · 24 May 2025 · 0 likes This follows post #46 rather than contradicting it. BPC-157's published evidence is overwhelmingly preclinical and mostly rodent. That is not a dismissal — it is the…
-
Follow-up: Documentation that appears only after payment Replied, post #81 · Sourcing › Red flags · 15 May 2025 · 2 likes What would change my mind on Documentation is a second dataset collected by someone with no stake in the first. Until then I hold it loosely and I would rather say so…
-
Semaglutide versus liraglutide head to head: reading STEP 8 carefully Replied, post #2 · Compounds › Semaglutide · 9 May 2025 · 24 likes On alcohol: the labelling does not contraindicate it, but it raises gastric irritation risk and semaglutide already does that. There is no published interaction study…
-
The report format the maintainers ask for, and why each field is there — what changed… Replied, post #25 · Sourcing › Vendor reports · 3 May 2025 · 0 likes Do not adjust a reported figure. Post what the laboratory said and put your interpretation in a separate sentence.
-
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #32 · Sourcing › Independent verification · 30 Apr 2025 · 0 likes Worth separating two things that post #30 runs together. Two claims get bundled together under Janoshik and they need separating. The descriptive one — this is what was…
-
Coming back to: An 18-month record including the parts that went badly Replied, post #44 · Outcomes › Progress reports · 26 Apr 2025 · 1 like I read post #42 twice before replying, because I had assumed the opposite. Adding a null result on 18-month record. I looked, carefully, and found nothing, and null…
-
When "no data" is the complete and final answer Replied, post #154 · Compounds › Other compounds · 20 Apr 2025 · 1 like Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature, which puts it in a different evidential category from most of its…
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #18 · Evidence › Journal club · 17 Apr 2025 · 4 likes STEP 1: I would want to see the raw numbers rather than the summary before agreeing. Summaries lose exactly the information that would settle this.
-
Why the timeline is on the right and not the left Replied, post #8 · Meta › Site feedback · 14 Apr 2025 · 0 likes Post #6 put the caveat in the right place and I want to underline it. Two sentences on timeline and then I will stop, because the rest is speculation and the thread is…
-
Deamidation and the close-eluting pair it produces Replied, post #23 · Analytics › Impurities & related substances · 10 Apr 2025 · 8 likes Everything in post #21 holds. The case it does not cover is the one I have. The most useful reply I ever got about deamidation was a request to state my units. It…
-
Revisiting: German, French and Dutch differences, compared Replied, post #10 · Regional › European Union · 9 Apr 2025 · 5 likes Understood. Thank you for being specific about the limits of it.
-
What the published dose-response for semaglutide actually looks like above 2.4 mg — a… Replied, post #123 · Compounds › Semaglutide · 29 Mar 2025 · 0 likes The confident answers on published dose-response for semaglutide and the well-sourced answers are not the same answers, which is the most useful thing I have learned…
-
Retatrutide dose escalation in the published trials Replied, post #46 · Compounds › Retatrutide · 24 Mar 2025 · 0 likes Glucagon receptor agonism seems paradoxical in a weight-loss compound because glucagon raises blood glucose. The paradox resolves because glucagon agonism also…
-
Why cagrilintide alone is discussed so much less than in combination Replied, post #20 · Compounds › Cagrilintide & amylin analogues · 24 Mar 2025 · 0 likes I had written a reply contradicting post #16 and deleted it. Here is what survived. The dosing interval: cagrilintide's half-life is roughly 7 to 8 days, suitable for…
-
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #109 · Evidence › Journal club · 29 Jan 2025 · 26 likes Building on post #107 rather than restating it. The baseline characteristics table is the single most useful page for the questions that get asked here, because it…
-
Bleeding at the injection site: normal, and what to do about it — does this still hold? Replied, post #2 · Practice › Administration · 29 Jan 2025 · 9 likes This is the first time the answer has come with its own limits attached. Appreciated.
-
Why the Start Here categories exist, and what they are not for — one year on Replied, post #7 · Start Here › Welcome · 28 Jan 2025 · 6 likes My experience of Start contradicts the reply above. I am posting it as a data point rather than as a refutation, because one person's experience is exactly that.
-
Isotope patterns and why the monoisotopic peak is not the tallest Replied, post #12 · Analytics › Mass spectrometry · 24 Jan 2025 · 31 likes Useful. I have added it to my own notes with the date on it.
-
Second pass at: Certificates issued by the seller versus by a laboratory Replied, post #47 · Analytics › COA interpretation · 23 Jan 2025 · 0 likes On post #46 — agreed on the reasoning, with one qualification. An itemised related-substances table with retention times says considerably more about the synthesis than…
-
EMA product information as a primary source — does this still hold? Replied, post #121 · Regional › European Union · 18 Nov 2024 · 0 likes Confirming post #120 from a second method, which matters more than confirming it from a second person. Regional stock held inside the union removes a customs question…
-
A page that has drifted out of date and needs a maintainer Replied, post #29 · Documentation › Wiki requests · 15 Nov 2024 · 19 likes Taking post #28 at face value and following it one step further. The most useful requests here identify a specific confusion that keeps recurring rather than a subject…
-
A revision dispute resolved on the topic rather than in the history — a second dataset Replied, post #28 · Meta › Wiki maintenance · 6 Nov 2024 · 31 likes I read the earlier replies on revision dispute resolved twice before writing this, because I had assumed the opposite and wanted to be sure I was disagreeing with what…
-
Transporting a vial for a weekend away Replied, post #36 · Practice › Storage & stability · 6 Nov 2024 · 3 likes Transporting a vial is a question about a distribution, not about a value, and treating it as a value is what produces the confident wrong answers.
-
Second pass at: Reimbursement variation across member states Replied, post #20 · Regional › European Union · 15 Oct 2024 · 21 likes Taking post #19 at face value and following it one step further. Small methodological point on Reimbursement variation across member states: repeating a measurement is…
-
PIONEER 6 cardiovascular safety, read as a safety trial rather than an efficacy one —… Replied, post #17 · Compounds › Oral incretins · 3 Sep 2024 · 0 likes Dose equivalence between oral and injectable formulations is not a simple conversion and no published factor should be used as one. The two were developed and titrated…
-
Correlation in a self-tracked dataset: what it can support Replied, post #8 · Research Methods › Statistics · 20 Aug 2024 · 15 likes Effect sizes: the magnitude of a difference, not just whether it is statistically significant. A difference that is significant (p
-
What a stability-indicating method is and how you demonstrate one — one year on Replied, post #9 · Analytics › Method validation · 31 Jul 2024 · 14 likes The distinction between a qualified instrument and a validated method is worth keeping. Both are needed and they fail in different ways.
-
Second pass at: Retatrutide dose escalation in the published trials Replied, post #111 · Compounds › Retatrutide · 23 Jul 2024 · 22 likes Reading back through, this was answered upthread and I missed it. My fault.
-
Assessing a warm arrival: the decision process — one year on Replied, post #85 · Sourcing › Logistics · 31 May 2024 · 0 likes Adding a reference point for Assessing a warm arrival. Mine is a single case, collected without controls, and I am posting the method alongside it so it can be…